Ligand-Based Drug Design

Ligand-Based Drug Design (LBDD) is a computational approach in drug discovery that focuses on analyzing known active molecules (ligands) to design new compounds with similar or improved biological activity. It relies on the principle that structurally similar molecules often exhibit similar biological effects, using techniques like quantitative structure-activity relationship (QSAR) modeling, pharmacophore modeling, and molecular similarity analysis. This method is particularly useful when the 3D structure of the target protein is unknown or difficult to obtain.

Also known as: LBDD, Ligand-Based Design, Structure-Activity Relationship Modeling, Pharmacophore-Based Design, Molecular Similarity Analysis

Why learn Ligand-Based Drug Design?

Developers should learn LBDD when working in pharmaceutical, biotech, or academic research settings to accelerate early-stage drug discovery by predicting the activity of new compounds without requiring detailed protein structural data. It is essential for virtual screening, lead optimization, and identifying novel drug candidates in projects targeting diseases like cancer, infectious diseases, or neurological disorders. This skill is valuable for roles involving cheminformatics, computational chemistry, or AI-driven drug design.

Learning Resources

• docs: Ligand-Based Drug Design - An Overview
• course: Introduction to Ligand-Based Drug Design on Coursera
• tutorial: Ligand-Based Virtual Screening Tutorial
• book: QSAR and Molecular Modeling in Drug Design - Book